PMID- 28292084 OWN - NLM STAT- MEDLINE DCOM- 20170404 LR - 20240324 IS - 1937-8688 (Electronic) VI - 25 DP - 2016 TI - [Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca]. PG - 121 LID - 10.11604/pamj.2016.25.121.9967 [doi] LID - 121 AB - Synchronous bilateral breast cancers (SBBC) are characterized by extensive clinical and morphological heterogeneity, with an frequency between 1.5 and 3.2%. Women treated for unilateral breast cancer are at higher risk of developing contralateral breast cancer. Screening and advances in breast imaging have improved detection rates of SBBC. Our study aims to analyze the epidemiological, clinical, histological and therapeutic features of bilateral breast cancer. We conducted a cross-sectional study of patients with breast cancer treated at the Mohammed VI Center over a two year period. Statistical analysis of the results was performed using R. software. 31 patients had SBBC, representing 2.4% of breast cancer cases in our Center. The average age was 47.8 +/- 8.4 years, 22.6% of patients used oral contraceptives. A family history of breast cancer was observed in 22.6% of cases. The most common histological type was invasive ductal carcinoma (58.1%), SBR grade II and III were common (38.7%). Hormone receptors were positive for progesterone (38.7%) and for estrogen (41.9%). HER2 was overexpressed in 20.0% of cases. 29.0% of patients received hormonal therapy and 3.2% targeted therapies. Our study showed that bilateral breast cancer represents a small percentage of all breast cancers but have specific clinical features that help to differentiate it from unilateral breast cancer. FAU - Khalil, Ahmadaye Ibrahim AU - Khalil AI AD - Laboratoire de Physiopathologie et Genetique Moleculaire, Faculte des Sciences Ben M'Sik, Universite Hassan II, Casablanca, Maroc. FAU - Bendahhou, Karima AU - Bendahhou K AD - Registre des Cancers de la Region du Grand Casablanca, Maroc. FAU - Mestaghanmi, Houriya AU - Mestaghanmi H AD - Laboratoire de Physiopathologie et Genetique Moleculaire, Faculte des Sciences Ben M'Sik, Universite Hassan II, Casablanca, Maroc. FAU - Saile, Rachid AU - Saile R AD - Laboratoire de Biologie et Sante, Unite de Recherche Associee au CNRST-URAC 34, Faculte des Sciences Ben M'Sik, Universite Hassan II, Casablanca, Maroc. FAU - Benider, Abdellatif AU - Benider A AD - Centre Mohammed VI pour le Traitement des Cancers, CHU Ibn Rochd Casablanca, Maroc. LA - fre PT - Journal Article TT - Cancer du sein bilateral synchrone: experiences du centre Mohammed VI pour le traitement des cancers CHU Ibn Rochd Casablanca. DEP - 20161027 PL - Uganda TA - Pan Afr Med J JT - The Pan African medical journal JID - 101517926 RN - 0 (Contraceptives, Oral) RN - 0 (Receptors, Estrogen) RN - 0 (Receptors, Progesterone) SB - IM MH - Adult MH - Aged MH - Breast Neoplasms/*pathology/therapy MH - Carcinoma, Ductal, Breast/epidemiology/*pathology/therapy MH - Contraceptives, Oral/administration & dosage MH - Cross-Sectional Studies MH - Female MH - Humans MH - Middle Aged MH - Morocco MH - Neoplasms, Multiple Primary/*pathology/therapy MH - Receptors, Estrogen/metabolism MH - Receptors, Progesterone/metabolism MH - Retrospective Studies PMC - PMC5325485 OTO - NOTNLM OT - Bilateral breast cancer OT - clinical OT - epidemiology OT - histology OT - therapeutic COIS- Les auteurs ne declarent aucun conflit d'interet. EDAT- 2017/03/16 06:00 MHDA- 2017/04/05 06:00 PMCR- 2016/10/27 CRDT- 2017/03/16 06:00 PHST- 2016/06/04 00:00 [received] PHST- 2016/09/22 00:00 [accepted] PHST- 2017/03/16 06:00 [entrez] PHST- 2017/03/16 06:00 [pubmed] PHST- 2017/04/05 06:00 [medline] PHST- 2016/10/27 00:00 [pmc-release] AID - PAMJ-25-121 [pii] AID - 10.11604/pamj.2016.25.121.9967 [doi] PST - epublish SO - Pan Afr Med J. 2016 Oct 27;25:121. doi: 10.11604/pamj.2016.25.121.9967. eCollection 2016.